Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00192075. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
ClinicalTrials.gov study NCT01647828. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00753675. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
ClinicalTrials.gov study NCT01905150. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00110084. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01663272. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00193453. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
ClinicalTrials.gov study NCT00066781. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00565851. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00326599. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung C
ClinicalTrials.gov study NCT01160744. IPD Sharing: YES. Countries: 6. Publications: 1.
Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC
ClinicalTrials.gov study NCT03629925. IPD Sharing: Not stated. Countries: 1. Publications: 2.
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
ClinicalTrials.gov study NCT00789958. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00769483. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT00057876. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT04524702. IPD Sharing: NO. Countries: 1. Publications: 1.
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
ClinicalTrials.gov study NCT01862315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00550836. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT02551991. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT03214250. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.